Study Details
A study to test if enzalutamide is effective and safe in prostate cancer patients who have never had hormone therapy
Clinicaltrials.gov ID
Astellas Study ID
9785-CL-0321
EudraCT ID
2010-021287-16
Condition
Prostate Cancer
Phase
Phase 2
Age
18 years - N/A
Sex
Male
Product
N/A
Type
Interventional
Trial Dates
May 2011 - Apr 2017
Masking
None (Open Label)
Enrollment number
67
A Phase 2, Open-label, Single-arm, Efficacy and Safety Study of Enzalutamide (MDV3100) in Patients with Hormone-naïve Prostate Cancer
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A study to test if enzalutamide is effective and safe in prostate cancer patients who have never had hormone therapy? Contact us by filling our your information to the right and we’ll respond to you.
Locations
Site DE5008
Tubingen, Germany, 72076
Site DE5005
Aachen, Germany, 51074
Site BE1002
Kortrijk, Belgium, 8500
Site BE1003
Brussels, Belgium, 1090
Site BE1005
Leuven, Belgium, 3000
Site BE1006
Turnhout, Belgium, 2300
Site DK4001
Aarhus N, Denmark, 8200
Site DK4002
Herlev, Denmark, 2730
Site BE1004
Edegem, Belgium, 2650
Site BE1001
Brussels, Belgium, 1200
Site DE5007
Bonn, Germany, 53111
Site DE5003
Hannover, Germany, 30625
Site DE5001
Bonn, Germany, 53105
Site CZ3006
Olomouc, Czech Republic, 77520
Site DK4004
Copenhagen, Denmark, DK-2100
Site CZ3002
Praha 6, Czech Republic, 16000
Site DK4003
Viborg, Denmark, 8800